Illumina, Inc. (ILMN)-Financial and Strategic SWOT Analysis Review
April 2017
61
About the Report
About the Report
Illumina, Inc. (ILMN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Illumina, Inc. (Illumina) provides sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company's portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company's products are distributed to various countries through its distributors in Africa, Asia Pacific, Central America, Europe, the Middle East, North America, and South America. Illumina is headquartered in San Diego, California, the US.
Illumina, Inc. Key Recent Developments
Apr 20,2017: Personalis Orders Ten Illumina NovaSeq 6000 Systems for Immuno-Oncology Genomics and Large-Scale Whole Genome Sequencing
Apr 10,2017: CloudHealth Genomics Makes China's First Sequencing Data Available Using Illumina's NovaSeq 6000
Apr 03,2017: Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViC
Apr 03,2017: Novogene Adds 25 Illumina NovaSeq Sequencers
Mar 28,2017: Macrogen Leads Precision Medicine by Advancing the Realization of the "$100 Genome Age"
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Companies
Qiagen NV Pacific Biosciences Inc Luminex Corp GenMark Diagnostics Inc Agilent Technologies, Inc. Affymetrix, Inc.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Illumina, Inc.-Key Facts 6
Illumina, Inc.-Key Employees 7
Illumina, Inc.-Key Employee Biographies 8
Illumina, Inc.-Major Products and Services 10
Illumina, Inc.-Medical Equipment Pipeline Products Data 12
Illumina, Inc. Pipeline Products by Equipment Type 12
Illumina, Inc. Pipeline Products by Development Stage 13
Illumina, Inc.-History 15
Illumina, Inc.-Company Statement 24
Illumina, Inc.-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 27
Section 2-Company Analysis 28
Illumina, Inc.-Business Description 28
Illumina, Inc.-Corporate Strategy 30
Illumina, Inc.-SWOT Analysis 31
SWOT Analysis-Overview 31
Illumina, Inc.-Strengths 31
Illumina, Inc.-Weaknesses 32
Illumina, Inc.-Opportunities 33
Illumina, Inc.-Threats 34
Illumina, Inc.-Key Competitors 35
Section 3-Company Financial Ratios 36
Financial Ratios-Capital Market Ratios 36
Financial Ratios-Annual Ratios 37
Performance Chart 40
Financial Performance 40
Financial Ratios-Interim Ratios 41
Financial Ratios-Ratio Charts 42
Section 4-Company's Lifesciences Financial Deals and Alliances 43
Illumina, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 43
Illumina, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017 44
Illumina, Inc., Recent Deals Summary 45
Section 5-Company's Recent Developments 46
Apr 10, 2017: CloudHealth Genomics Makes China's First Sequencing Data Available Using Illumina's NovaSeq 6000 46
Apr 03, 2017: Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViC 47
Apr 03, 2017: Novogene Adds 25 Illumina NovaSeq Sequencers 48
Feb 20, 2017: Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina 49
Jan 31, 2017: Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016 50
Jan 27, 2017: Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries 52
Jan 09, 2017: Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases 53
Jan 09, 2017: Illumina Introduces the NovaSeq Series-a New Architecture Designed to Usher in the $100 Genome 54
Jan 03, 2017: Illumina Taps Garret Hampton, One of the World's Leading Clinical Genomics Experts, to Head its Clinical Genomics Unit 55
Dec 20, 2016: Illumina Names Jonathan Seaton as Senior Vice President for Corporate & Business Development, Adding Further Clinical and Life Sciences Expertise to its Executive Team 56
Section 6-Appendix 57
Methodology 57
Ratio Definitions 57
About GlobalData 61
Contact Us 61
Disclaimer 61
List of Figure
List of Figures
Illumina, Inc. Pipeline Products by Equipment Type 12
Illumina, Inc. Pipeline Products by Development Stage 13
Illumina, Inc., Performance Chart (2012-2016) 40
Illumina, Inc., Ratio Charts 42
Illumina, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 43
Illumina, Inc., Medical Equipment, Deals by Type, 2011 to YTD 2017 44
List of Table
List of Tables
Illumina, Inc., Key Facts 6
Illumina, Inc., Key Employees 7
Illumina, Inc., Key Employee Biographies 8
Illumina, Inc., Major Products and Services 10
Illumina, Inc. Pipeline Products by Equipment Type 12
Illumina, Inc. Number of Pipeline Products by Development Stage 13
Illumina, Inc. Pipeline Products Summary by Development Stage 14
Illumina, Inc., History 15
Illumina, Inc., Other Locations 25
Illumina, Inc., Subsidiaries 25
Illumina, Inc., Joint Venture 27
Illumina, Inc., Key Competitors 35
Illumina, Inc., Ratios based on current share price 36
Illumina, Inc., Annual Ratios 37
Illumina, Inc., Annual Ratios (Cont...1) 38
Illumina, Inc., Annual Ratios (Cont...2) 39
Illumina, Inc., Interim Ratios 41
Illumina, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 43
Illumina, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017 44
Illumina, Inc., Recent Deals Summary 45
Currency Codes 57
Capital Market Ratios 57
Equity Ratios 58
Profitability Ratios 58
Cost Ratios 59
Liquidity Ratios 59
Leverage Ratios 60
Efficiency Ratios 60
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.